Compare · MAMO vs SNN
MAMO vs SNN
Side-by-side comparison of Massimo Group (MAMO) and Smith & Nephew SNATS Inc. (SNN): market cap, price performance, sector, and recent activity on the wire.
Summary
- MAMO operates in Consumer Discretionary, while SNN operates in Health Care - the two are in different parts of the market.
- SNN is the larger of the two at $11.13B, about 270.7x MAMO ($41.1M).
- Over the past year, MAMO is down 67.1% and SNN is down 27.2% - SNN leads by 39.8 points.
- SNN has been more active in the news (25 items in the past 4 weeks vs 2 for MAMO).
- SNN has more recent analyst coverage (25 ratings vs 0 for MAMO).
- Company
- Massimo Group
- Smith & Nephew SNATS Inc.
- Price
- $0.97-2.79%
- $26.43-0.53%
- Market cap
- $41.1M
- $11.13B
- 1M return
- -3.83%
- -7.83%
- 1Y return
- -67.07%
- -27.23%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 2024
- News (4w)
- 2
- 25
- Recent ratings
- 0
- 25
Smith & Nephew SNATS Inc.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Latest MAMO
- SEC Form 8-K filed by Massimo Group
- Massimo Group Launches Retro-Inspired Mini Truck Exclusively at Tractor Supply for 2026 Holiday Season
- Massimo Group to Unveil New Warrior 1500 UTV at Equip Exposition and Showcase Next-Generation Product Platform at 2026 SEMA Show
- Massimo Group Adds Navy MWR as Fleet Customer, Expanding Government and Military-Related Sales Channel
- SEC Form 10-Q filed by Massimo Group
- Massimo Group filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events
- Massimo Group Secures Up to US$4 Million in Controlling Shareholder Funding to Accelerate Intelligent Patrol Systems Development and Terminates Previously Announced FST Acquisition
- Massimo Group Announces Confirmed U.S. Department of Defense and U.S. Army Fleet Orders
- SEC Form 8-K filed by Massimo Group
- Massimo Group Begins Revenue-Generating Fulfillment for Large-Scale Tractor Supply Retail Program
Latest SNN
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- MULTIMEDIA UPDATE: Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
- Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
- Natural design. Amplified: Smith+Nephew announces FDA 510(k) clearance and first surgical cases of LANDMARK™ Total Knee System
- Smith+Nephew to showcase leading shoulder technologies for joint repair and reconstruction at ICSES 2026
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form CERT filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.